Mr. Bruce Linton reports

BEDROCAN CONTINUES COMMITMENT TO AFFORDABILITY

Bedrocan Canada, a wholly owned subsidiary of Canopy Growth Corp., is continuing its commitment to affordable medical cannabis treatment by offering vaporizers at cost. The offer, available to all registered Bedrocan Canada clients, is a part of a wider effort to reduce the cost of medicating with cannabis.

"Bedrocan is fully engaged with the medical community and respects the concern many physicians have with inhaling burnt plant matter as a means to medicate," said Marc Wayne, Bedrocan Canada's President. "Offering deep discounts on vaporizers is a way to address this concern by making alternative therapy applications more affordable."

Bedrocan Canada already offers the most affordable full line of standardized cannabis varieties in the country. Via true compassionate pricing, all Bedrocan varieties cost $5 per gram for all registered clients.

"Bedrocan Canada is and will always be a medical cannabis company," said Bruce Linton, chief executive officer of Canopy Growth. "Canada's cannabis laws are evolving but Bedrocan Canada is focused on advancements on the medical side of the industry. By advocating for tax amendments, co-ordinating research initiatives and facilitating physician education, the team at Bedrocan Canada remains focused on its core business."

We seek Safe Harbor.